| - candidate number | 0 |
|
| - NTR Number | NTR82 |
|
| - ISRCTN | ISRCTN92577199 |
|
| - Date ISRCTN created | 12-sep-2005 |
|
| - date ISRCTN requested | 15-aug-2005 |
|
| - Date Registered NTR | 4-jul-2005 |
|
| - Secondary IDs | N/A |
|
| - Public Title | Efficacy of inhaled DNase in admitted infants with RSV-bronchiolitis. |
|
| - Scientific Title | Efficacy of inhaled DNase in admitted infants with RSV-bronchiolitis. |
|
| - ACRONYM | N/A |
|
| - hypothesis | Nebulised DNase has a decreasing effect on the duration of a hospital admission in
infants admitted with an RSV-bronchiolitis.
|
|
| - Healt Condition(s) or Problem(s) studied | Respiratory syncytial virus (RSV) bronchiolitis, Bronchiolitis |
|
| - Inclusion criteria | 1. RSV bronchiolitis with need for additional oxygen (saturation ¡Ü 92 %);
2. RSV-infection proven with rapid assay or culture;
3. Age < 12 months ;
4. Admission on (medium care) ward;
5. Study medication can be started within 24 hours. |
|
| - Exclusion criteria | 1. Premature birth (born < 32 weeks of gestation);
2. Congenital heart disease;
3. Pre-existent lung disease (e.g. BPD or CF);
4. T-cel immune deficiency;
5. Pre-treatment with systemic steroids.
|
|
| - mec approval received | yes |
|
| - multicenter trial | yes |
|
| - randomised | yes |
|
| - masking/blinding | Double |
|
| - control | Placebo |
|
| - group | Parallel |
|
| - Type | 2 or more arms, randomized |
|
| - Studytype | intervention |
|
| - planned startdate | 1-dec-2002 |
|
| - planned closingdate | 1-apr-2006 |
|
| - Target number of participants | 180 |
|
| - Interventions | Twice daily 2,5 mg DNase or placebo during admission. |
|
| - Primary outcome | Length of stay and symptom score. |
|
| - Secondary outcome | Duration of oxygen suppletion, need
for ICU-admission.
|
|
| - Timepoints | N/A |
|
| - Trial web site | N/A |
|
| - status | stopped: trial finished |
|
| - CONTACT FOR PUBLIC QUERIES | MD. R. Boogaard |
|
| - CONTACT for SCIENTIFIC QUERIES | MD. R. Boogaard |
|
| - Sponsor/Initiator | Erasmus Medical Center, Sophia Children's Hospital |
|
- Funding
(Source(s) of Monetary or Material Support) | Roche Nederland BV |
|
| - Publications | Chest. 2007 Mar;131(3):788-95. |
|
| - Brief summary | N/A |
|
| - Main changes (audit trail) | |
|
|
| - RECORD | 15-aug-2005 - 11-nov-2008 |